Listed

Elite Pharmaceuticals Inc

ELTPOTCCIK 1053369HealthcareFiscal year ends Mar 31

Reports and events: 320 filings

Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.

What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.

Elite Pharmaceuticals Inc, Reports and events
FiledFormWhat it isAccession number
2026-08-1320:17 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001493152-26-037787
2026-08-1320:06 ET10-QQuarterly reportPeriod 2026-06-300001493152-26-037752
2026-08-1100:16 ET8-K/A7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001493152-26-036936
2026-08-1021:07 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001493152-26-036905
2026-08-0411:05 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001493152-26-035922
2026-06-2920:51 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001493152-26-031103
2026-06-2920:05 ET10-KAnnual reportPeriod 2026-03-310001493152-26-031070
2026-06-2311:02 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001493152-26-029700
2026-06-1511:02 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001493152-26-028610
2026-06-0111:00 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001493152-26-026519
2026-04-0212:05 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001493152-26-014813
2026-02-1722:10 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001493152-26-007190
2026-02-1721:06 ET10-QQuarterly reportPeriod 2025-12-310001493152-26-007104
2026-02-1121:35 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001493152-26-006213
2025-11-1422:10 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001493152-25-023629
2025-11-1421:11 ET10-QQuarterly reportPeriod 2025-09-300001493152-25-023477
2025-11-1222:19 ET8-K/A7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001493152-25-022013
2025-11-1212:15 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001493152-25-021717
2025-11-1012:15 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001493152-25-021392
2025-08-1420:37 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001641172-25-024088
2025-08-1420:16 ET10-QQuarterly reportPeriod 2025-06-300001493152-25-011989
2025-08-0820:35 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001493152-25-011765
2025-06-3020:27 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001641172-25-017151
2025-06-3020:05 ET10-KAnnual reportPeriod 2025-03-310001641172-25-017134
2025-06-2311:05 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001641172-25-016000
2025-06-1611:05 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001641172-25-015172
2025-04-3020:40 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001641172-25-007836
2025-03-0312:10 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001493152-25-008808
2025-02-1321:56 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001493152-25-006471
2025-02-1321:05 ET10-QQuarterly reportPeriod 2024-12-310001493152-25-006427
2024-12-2621:20 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001493152-24-052104
2024-12-0221:35 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001493152-24-048294
2024-11-1821:35 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001493152-24-046525
2024-11-1421:51 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001493152-24-046001
2024-11-1421:30 ET10-QQuarterly reportPeriod 2024-09-300001493152-24-045933
2024-10-1020:47 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001493152-24-040752
2024-10-0720:20 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001493152-24-040288
2024-08-2720:30 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001493152-24-034019
2024-08-1421:16 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001493152-24-032412
2024-08-1420:05 ET10-QQuarterly reportPeriod 2024-06-300001493152-24-032154
2024-07-0121:21 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001493152-24-025848
2024-07-0120:59 ET10-KAnnual reportPeriod 2024-03-310001493152-24-025829
2024-06-2120:07 ET8-K1.01 Entry into a material agreement0001493152-24-024720
2024-06-0520:07 ET8-K4.01 Change of auditor; 9.01 Financial statements and exhibits0001493152-24-022732
2024-05-2020:30 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001493152-24-020707
2024-02-1421:55 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001493152-24-006722
2024-02-1421:06 ET10-QQuarterly reportPeriod 2023-12-310001493152-24-006661
2023-12-2621:20 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001493152-23-046142
2023-12-1221:20 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001493152-23-044556
2023-11-1422:22 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001493152-23-041323

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:03 ET. Listed shows no prices and gives no investment advice.